Overexpression of asparagine synthetase in albizziin-resistant murine diploid embryonic stem cells.
C Wei, I L Andrulis
Index: Somat. Cell Mol. Genet. 19(4) , 321-30, (1993)
Full Text: HTML
Abstract
Gene amplification is commonly observed in primary tumors and established drug-resistant cell lines, both of which are generally aneuploid. However, this process is undetectable (frequency < 10(-9) in normal diploid mammalian cell lines. To investigate whether gene amplification can occur in pluripotent diploid cells, we have selected drug-resistant mutants of mouse embryonic stem (ES) cells. We had previously found that Chinese hamster ovary (CHO) and human cell lines selected in albizziin (Alb), an amino acid analog of L-glutamine, overexpress asparagine synthetase (AS) due to gene amplification. The same drug selection system was applied to ES cells to isolate single-step and multistep drug-resistant mutants. Albizziin-resistant ES cells exhibited elevated levels of AS; however, drug resistance in ES cells was associated with mRNA overexpression without gene amplification. AS gene amplification was observed in only one drug-resistant cell line and was preceded by AS mRNA overexpression. Gene amplification in the latter coincided with the loss of the pluripotent nature of the ES cells.
Related Compounds
Related Articles:
1990-01-01
[Somat. Cell Mol. Genet. 16(1) , 59-65, (1990)]
1983-03-01
[Mol. Cell. Biol. 3(3) , 391-8, (1983)]
1987-05-01
[Mol. Cell. Biol. 7(5) , 1623-8, (1987)]
1985-06-25
[J. Biol. Chem. 260(12) , 7523-7, (1985)]
1989-12-01
[Biochem. Pharmacol. 38(23) , 4327-32, (1989)]